Bausch Health Companies Inc BHC
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover BHC, but with our powerful screener, you can find
stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
Health Canada Approves (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Triple-Combination Topical Treatment for Acne Vulgaris in Patients 12 Years of Age and Older
-
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners
-
Bausch Health Announces Second Quarter 2024 Results
-
Bausch Health responds to rumors, says it is not considering bankruptcy
-
Bausch Health Responds to Market Rumors
-
Bausch Health Welcomes Two New Members to the Executive Leadership Team
-
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
-
Toronto Stocks Climb, Loblaw Shares Rise on 4Q Profit, Revenue Growth
Trading Information
- Previous Close Price
- $8.11
- Day Range
- $8.10–8.28
- 52-Week Range
- $3.96–11.46
- Bid/Ask
- $8.20 / $8.35
- Market Cap
- $3.03 Bil
- Volume/Avg
- 1.6 Mil / 3.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 2.24
- Price/Sales
- 0.33
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 20,270
- Website
- https://www.bauschhealth.com
Comparables
Valuation
|
Metric
|
BHC
|
CPH
|
301267
|
|---|---|---|---|
Price/Earnings (Normalized) | 2.24 | 20.76 | 22.10 |
Price/Book Value | — | 2.88 | 3.04 |
Price/Sales | 0.33 | 12.03 | 4.20 |
Price/Cash Flow | 1.91 | 13.17 | 19.11 |
Price/Earnings
BHC
CPH
301267
Financial Strength
|
Metric
|
BHC
|
CPH
|
301267
|
|---|---|---|---|
Quick Ratio | 0.62 | 10.53 | 3.67 |
Current Ratio | 1.19 | 11.18 | 4.20 |
Interest Coverage | 0.73 | — | 19.41 |
Quick Ratio
BHC
CPH
301267
Profitability
|
Metric
|
BHC
|
CPH
|
301267
|
|---|---|---|---|
Return on Assets (Normalized) | 5.00% | 27.34% | 7.63% |
Return on Equity (Normalized) | — | 30.12% | 10.31% |
Return on Invested Capital (Normalized) | 11.52% | 27.63% | 9.05% |
Return on Assets
BHC
CPH
301267
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Ymxhfrgr | Hxhj | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Vkhvgrkt | Rggnj | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Crmzzfz | Vyt | $48.4 Bil | |||
| Viatris Inc
VTRS
| Thllbqqk | Whkc | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Czdksppy | Nrl | $13.5 Bil | |||
| Catalent Inc
CTLT
| Jkhbggkz | Ptlnjx | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Vcvjjnr | Gvcwysy | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Bphzmqqs | Ktbvm | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Dgzqzqllp | Pfyvb | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Dvctdvk | Sxzg | $2.3 Bil |
United States